Training Course Blog

The Khavinson Bioregulator Model
The research framework behind Chonluten traces to work begun in the early 1970s by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. That body of research established a class of short peptides isolated from specific animal organs, each displaying preferential biological activity in the corresponding tissue type.

The compounds were called cytomedines — tissue-derived regulatory peptides hypothesized to modulate cellular differentiation, proliferation, and intercellular signaling. Among the compounds characterized through this program was a tripeptide derived from bronchial epithelial cells: what would become Chonluten. buy dsip

Epitalon, derived from pineal gland tissue, and Vilon, a dipeptide with immune system activity, were characterized through the same research program. The tissue-specific profiles of these compounds became a defining feature of the bioregulator model.

How Short Peptides Interact with Gene Promoters
The proposed mechanism separating Khavinson-class bioregulators from conventional receptor-based compounds is their apparent interaction with DNA directly.

According to a 2021 systematic review published in Molecules by Khavinson and colleagues, short peptides of 2–7 amino acid residues can penetrate cellular and nuclear membranes, interact with nucleosome histone proteins, and bind to specific sequences in gene promoter regions.[1]

Rather than activating a surface receptor and initiating a downstream cascade, these peptides appear to interact with transcriptional architecture at the source — modulating which genes get expressed without introducing an external molecular signal.

The review documents this across multiple compounds. Chonluten, as a Glu-Asp-Gly tripeptide carrying acidic residues (glutamic acid, aspartic acid), falls within the structural class examined in these DNA-binding analyses.

DNA methylation status was also identified in the review as a variable that short peptides can both read and potentially influence — a finding with implications for how researchers model epigenetic regulation in aged or stressed cell populations.

Chonluten in Bronchopulmonary Research Models
Preclinical and in vitro investigations position Chonluten’s primary research activity in bronchopulmonary tissue. Bronchial epithelial and alveolar cell models have been used to examine how the compound interacts with pathways tied to mucosal homeostasis and inflammatory gene regulation.

Antioxidant Gene Pathway Observations
Research literature on Khavinson bronchial bioregulators identifies antioxidant gene networks as a primary area of observed modulation.[2]

Genes associated with superoxide dismutase (SOD) activity and glutathione-related regulatory pathways appear in discussions of how short peptide bioregulators affect oxidative conditions in bronchial epithelial models.

The proposed mechanism: peptide interaction with the promoter regions of genes encoding these antioxidant proteins, altering their transcriptional availability in stressed cell environments. The result, as framed in the bioregulator literature, is a shift in redox balance rather than a direct antioxidant chemical contribution.